Undisclosed oral obesity therapeutic / Huons - LARVOL DELTA

Huons to unveil preclinical data on GI, oral obesity drug candidates at global meetings (Korea Biomedical Review) - "Huons will unveil preclinical data on investigational gastrointestinal and oral obesity drug candidates at two global conferences later this year after the studies were selected as late-breaking abstracts (LBAs)...Huons plans to present preclinical findings on an investigational drug candidate it is developing for gastrointestinal diseases at UEG Week 2026 later this month...This year’s meeting will be held in Barcelona, Spain, from Oct. 17 to 20...Huons will then present preclinical findings on its investigational oral obesity drug candidate at Obesity Week 2026 in the United States in November."

Preclinical • Obesity